Citations

Mayo Clinic

Showing 10 of 108602 citations.

The MIDA Mortality Risk Score: development and external validation of a prognostic model for early and late death in degenerative mitral regurgitation
Grigioni, Francesco , Clavel, Marie‐Annick , Tribouilloy, Christophe, Pizarro, Rodolfo , Huebner, Marianne , Aviérinos, Jean-François , Barbieri, Andréa , Suri, Rakesh M. , Ruşinaru, Dan, Gargiulo, Gaetano , Oberti, Pablo , Bursi, Francesca , Lazam, Siham, Szymanski, Catherine, Reggiani, Maria Letizia Bacchi , Enriquez‐Sarano, Maurice , Investigators, MIDA, Tribouilloy, C, Trojette, F, Szymanski, C., Touati, Gilles, Remadi, J.-P., Pasquale, F, Ferlito, Marinella, Rapezzi, C., Boulif, Jamila, Meester, Christophe de , Khoury, Gébrine El , Lazam, S, Noirhomme, Philippe, Vanoverschelde, J-L, Collard, F., Lugli, R. , Maalouf, Joseph F., Nkomo, Vuyisile T, Michelena, Hector, Vanoverschelde, Jean‐Louis , Tribouilloy, Christophe , Pasquet, Agnès , Théron, Alexis , Michelena, Héctor I. , Nkomo, Vuyisile T. , Schumacher, Martin Christian , Investigators, MIDA, Trojette, Faouzi, Russo, Antonio , Biagini, Elena , Savini, Carlo , Marinelli, Giuseppe , Pacini, Davide , Bartolomeo, Roberto Di , Corazza, Ivan , Gerber, Bernhard , Vancraeynest, David , Vanoverschelde, J-L, Habib, Gilbert , Mantovani, Francesca , Modena, Maria Grazia , Boriani, Giuseppe , Nkomo, Vuyisile T, Enriquez-Sarano, Maurice , Barbieri, Andrea , Clavel, Marie-Annick , Bursi, Francesca , Grigioni, Francesco

European Heart Journal | July 24, 2017 | Volume: 39 | Issue: 15 | Pages: 1281-1291

10.1093/eurheartj/ehx465 | PMID 29020352 Get It

Unilateral vestibular schwannoma and meningiomas in a patient with PIK3CA‐related segmental overgrowth: Co‐occurrence of mosaicism for 2 rare disorders
Mills, John R. , Moyer, Ann M. , Kipp, Benjamin R. , Poplawski, A.B., Messiaen, Ludwine , Babovic‐Vuksanovic, Dusica , Mills, J R

Clinical Genetics | July 24, 2017 | Volume: 93 | Issue: 1 | Pages: 187-190

10.1111/cge.13099 | PMID 28737257 Get It

A 28‐year‐old female with PIK3CA‐related segmental overgrowth presented with headaches. She also had a unilateral vestibular schwannoma (VS), as well as 3 small (<2 cm) meningiomas, which according to the Manchester consensus diagnostic criteria for neurofibromatosis 2 (NF2) is sufficient for a clinical diagnosis. Analysis of blood revealed a mosaic PIK3CA c.2740G>A (p.Gly914Arg) mutation, confirming the diagnosis of PIK3CA‐related overgrowth, but no mutations in NF2 were detected. Although VS has not previously been reported in PIK3CA‐related segmental overgrowth, meningiomas have, raising the question of whether this patient's VS and meningiomas represent coincidental NF2 or phenotypic extension of her overgrowth syndrome. Genetic analysis of the VS revealed a heterozygous NF2 mutation c.784C>T (p.Arg262Ter) and loss of a portion of 22q, including NF2, SMARCB1, and LZTR1 genes. These results suggest that the patient has 2 different mosaic disorders, NF2 and PIK3CA‐related overgrowth. The PIK3CA mutation was also present in the VS. Confirmation of the clinical diagnosis of mosaic NF2 in this patient has implications for monitoring and highlights the possibility of co‐occurrence of mosaicism for multiple rare disorders in a single patient.
Lateral Ulnar Collateral Ligament Reconstruction for Posterolateral Rotatory Instability of the Elbow
Shields, Maegan N. , O’Driscoll, Shawn W. , Sanchez-Sotelo, Joaquin, O'Driscoll, Shawn W., Camp, Christopher L. , Sánchez‐Sotelo, Joaquín , Fitzsimmons, James S , Shields, Maegan N.

Arthroscopy Techniques | July 24, 2017 | Volume: 6 | Issue: 4 | Pages: No page available

10.1016/j.eats.2017.03.029 | PMID 29354404 Get It

Abstract Reconstruction of the lateral ulnar collateral ligament of the elbow is the primary treatment for recurrent symptomatic posterolateral rotatory instability. Although a number of lateral ulnar collateral ligament reconstruction techniques have been described, the docking technique has received general acceptance. In this technique, the graft is passed through a tunnel on the ulnar side and the 2 free limbs are docked into the humerus at the isometric point on the lateral condyle. Advantages of this method of reconstruction include reduced bone removal, decreased soft tissue damage, and precise control of graft tensioning. When precise surgical steps are followed, this technique can be performed in a reliable, efficient, and reproducible manner for patients with posterolateral rotatory instability of the elbow. Technique Video video See video under supplementary data.
Postoperative stereotactic radiosurgery for limited brain metastases: are we ready for prime time?
Lo, Simon S. , Brown, Paul D. , Foote, Matthew , Chao, Samuel T. , Chang, Eric L. , Sahgal, Arjun

Expert Review of Anticancer Therapy | July 24, 2017 | Volume: 17 | Issue: 9 | Pages: 775-777

10.1080/14737140.2017.1358090 | PMID 28737065 Get It

NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
Xiao, Zhijie , Wang, Si-Qi, Zhu, Yun , Gao, Xu-Yuan, Tin, Vicky Pui‐Chi, Qin, Jing , Wang, Junwen , Wong, Maria Pik , Xiao, Zhi-Jie , Wang, Jun-Wen, Wong, Maria Pik , Liu, Jing , Gao, Xu-Yuan, Wang, Junwen , Qin, Jing

eLife | July 24, 2017 | Volume: 6 | Issue: No issue available | Pages: No page available

10.7554/elife.26733 | PMID 28737489 Get It

Tumor-initiating cells (TIC) are dynamic cancer cell subsets that display enhanced tumor functions and resilience to treatment but the mechanism of TIC induction or maintenance in lung cancer is not fully understood. In this study, we show the calcium pathway transcription factor NFATc2 is a novel regulator of lung TIC phenotypes, including tumorspheres, cell motility, tumorigenesis, as well as in vitro and in vivo responses to chemotherapy and targeted therapy. In human lung cancers, high NFATc2 expression predicted poor tumor differentiation, adverse recurrence-free and cancer-specific overall survivals. Mechanistic investigations identified NFATc2 response elements in the 3’ enhancer region of SOX2, and NFATc2/SOX2 coupling upregulates ALDH1A1 by binding to its 5’ enhancer. Through this axis, oxidative stress induced by cancer drug treatment is attenuated, leading to increased resistance in a mutation-independent manner. Targeting this axis provides a novel approach for the long-term treatment of lung cancer through TIC elimination.
Nonoperative Management of Osteochondritis Dissecans of the Knee: Progression to Osteoarthritis and Arthroplasty at Mean 13-Year Follow-up
Sanders, Thomas L. , Pareek, Ayoosh , Johnson, Nick R., Carey, James L. , Krych, Aaron J. , Maak, Travis G. , Stuart, Michael J. , Krych, Aaron J

Orthopaedic Journal of Sports Medicine | July 24, 2017 | Volume: 5 | Issue: 7 | Pages: No page available

10.1177/2325967117704644 | PMID 28812032 Get It

Background: Osteochondritis dissecans (OCD) is a disorder of subchondral bone that commonly affects the knee. Purpose: To (1) evaluate the rate of arthritis and knee arthroplasty in a population-based cohort of patients with OCD lesions treated nonoperatively and (2) evaluate factors that may predispose patients to knee osteoarthritis and arthroplasty. Study Design: Case series; Level of evidence, 4. Methods: Eighty-six patients (mean age, 21.4 years) with OCD lesions treated nonoperatively were identified between 1976 and 2014. Information related to the diagnosis, laterality of lesion, details of treatment, and progression to arthritis was obtained from the medical record. Factors predictive of arthritis and arthroplasty (age, sex, body mass index [BMI], and lesion location) were examined. Results: At a mean ± SD follow-up of 12.6 ± 9.8 years from diagnosis, 13 patients (15%) were diagnosed with arthritis, corresponding to a cumulative incidence of 5.0% at 5 years, 10.0% at 10 years, 20.0% at 25 years, and 30.0% at 35 years. The cumulative incidence of arthroplasty was 1.0% at 5 years, 3.0% at 10 years, 8.0% at 25 years, and 8.0% at 35 years. BMI at diagnosis greater than 25 kg/m 2 (hazard ratio [HR], 15.4; 95% CI, 1.9-124.5), patellar OCD lesions (HR, 15.0; 95% CI, 1.3-345.3), and diagnosis as an adult (HR, 21.7; 95% CI, 2.7-176.3) were factors associated with an increased risk of arthritis. Conclusion: Arthritis after nonoperative treatment of OCD lesions is a challenging problem, with an estimated 30% cumulative incidence at 35 years after diagnosis. In contrast, the long-term rate of arthroplasty is low. BMI at diagnosis greater than 25 kg/m 2 and patellar OCD lesions are predisposing factors for arthritis. Diagnosis of OCD as an adult was associated with a greater risk of arthritis.
Grade I diastolic dysfunction and elevated left ventricular end‐diastolic pressure: Mitral Doppler inflow, pulmonary vein atrial reversal, and the M‐mode mitral B‐bump
Kerut, Edmund Kenneth , McIlwain, Elizabeth, Kerut, Edmund K , Nishimura, Rick A.

Echocardiography | July 24, 2017 | Volume: 34 | Issue: 9 | Pages: 1371-1373

10.1111/echo.13631 | PMID 28737016 Get It

Grade I diastolic dysfunction (DD) is generally associated with a normal mean left atrial pressure (LAP) and normal left ventricular end‐diastolic pressure (LVEDP). The first hemodynamic alteration seen in DD, however, is the development of an elevated LVEDP with a persistent normal LAP. This is manifested by echocardiography as a continued mitral pulsed wave (PW) E/A <0.8 (Grade I DD), but with evidence of an elevated LVEDP. Such findings include alterations in PV flow, mitral PW inflow response to Valsalva maneuver, and also the presence of a B‐bump on the mitral M‐mode tracing. When assessing diastolic function, it may be clinically helpful to assess for this early hemodynamic manifestation of DD.
Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer
Du, Meijun , Giridhar, Karthik V. , Tian, Yijun , Tschannen, Michael, Zhu, Jing , Huang, Chiang‐Ching , Kilari, Deepak , Kohli, Manish , Wang, Liang , Giridhar, Karthik V , Kohli, Manish

Oncotarget | July 23, 2017 | Volume: 8 | Issue: 38 | Pages: 63703-63714

10.18632/oncotarget.19476 | PMID 28969022 Get It

Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study
Kinnunen, Kirsi M. , Cash, David M. , Poole, Teresa, Frost, Chris , Benzinger, Tammie L.S. , Ahsan, R. Laila, Leung, Kelvin K., Cardoso, M. Jorge , Modat, Marc , Malone, Ian B. , Morris, John C. , Bateman, Randall J. , Marcus, Daniel S. , Goate, Alison , Salloway, Stephen , Correia, Stephen , Chhatwal, Jasmeer P. , Mayeux, Richard , Martins, Ralph N. , Farlow, Martin R. , Saykin, Andrew J. , Jack, Clifford R. , Schofield, Peter R. , Weiner, Michael W. , Ringman, John M. , Thompson, Paul M. , Masters, Colin L. , Rossor, Martin N. , Ourselin, Sébastien , Fox, Nick C. , (DIAN), Dominantly Inherited Alzheimer Network, Sperling, Reisa Anne , Brickman, Adam M. , Ghetti, Bernardino , McDade, Eric , Rowe, Christopher Cleon , (DIAN), Dominantly Inherited Alzheimer Network, Jack, Clifford R , Saykin, Andrew J , Schofield, Peter R , Thompson, Paul M , Bateman, Randall J , Masters, Colin L , Benzinger, Tammie L S , Fox, Nick C , Morris, John C , Cash, David M , Goate, Alison M

Alzheimer's & Dementia | July 22, 2017 | Volume: 14 | Issue: 1 | Pages: 43-53

10.1016/j.jalz.2017.06.2268 | PMID 28738187 Get It

Abstract Introduction Identifying at what point atrophy rates first change in Alzheimer's disease is important for informing design of presymptomatic trials. Methods Serial T1‐weighted magnetic resonance imaging scans of 94 participants (28 noncarriers, 66 carriers) from the Dominantly Inherited Alzheimer Network were used to measure brain, ventricular, and hippocampal atrophy rates. For each structure, nonlinear mixed‐effects models estimated the change‐points when atrophy rates deviate from normal and the rates of change before and after this point. Results Atrophy increased after the change‐point, which occurred 1–1.5 years (assuming a single step change in atrophy rate) or 3–8 years (assuming gradual acceleration of atrophy) before expected symptom onset. At expected symptom onset, estimated atrophy rates were at least 3.6 times than those before the change‐point. Discussion Atrophy rates are pathologically increased up to seven years before “expected onset”. During this period, atrophy rates may be useful for inclusion and tracking of disease progression.